open-discussion
open-discussion > RE: running interaction with shapeAnalysisMANCOVA
Nov 18, 2015 04:11 PM | Lara Foland-Ross - Stanford University
RE: running interaction with shapeAnalysisMANCOVA
Thanks so much for the quick response. Here are the first few rows:
diagnosis,sex,diagnosis_sex_interaction,Scaling,File,tbv,tbv_dm,age,age_dm
1,0,0,1,/media/sf_Spharm/14753.1/spharm/14753.1_Lhipp_surfSPHARM_ellalign.vtk,0.1618064,0.007095606,5.61,-1.384223301
0,0,0,1,/media/sf_Spharm/15397.1/spharm/15397.1_Lhipp_surfSPHARM_ellalign.vtk,0.1607335,0.006022706,6.75,-0.244223301
1,0,0,1,/media/sf_Spharm/15403.1/spharm/15403.1_Lhipp_surfSPHARM_ellalign.vtk,0.1522853,-0.002425494,7.82,0.825776699
0,0,0,1,/media/sf_Spharm/15407.1/spharm/15407.1_Lhipp_surfSPHARM_ellalign.vtk,0.1629996,0.008288806,4.86,-2.134223301
1,0,0,1,/media/sf_Spharm/15433.1/spharm/15433.1_Lhipp_surfSPHARM_ellalign.vtk,0.1516102,-0.003100594,5.15,-1.844223301
0,0,0,1,/media/sf_Spharm/15461.1/spharm/15461.1_Lhipp_surfSPHARM_ellalign.vtk,0.1483783,-0.006332494,7.37,0.375776699
1,0,0,1,/media/sf_Spharm/15462.1/spharm/15462.1_Lhipp_surfSPHARM_ellalign.vtk,0.1542314,-0.000479394,6.91,-0.084223301
1,0,0,1,/media/sf_Spharm/15467.1/spharm/15467.1_Lhipp_surfSPHARM_ellalign.vtk,0.1723395,0.017628706,6.26,-0.734223301
1,0,0,1,/media/sf_Spharm/15473.1/spharm/15473.1_Lhipp_surfSPHARM_ellalign.vtk,0.1689724,0.014261606,6.11,-0.884223301
Thanks again,
Lara
diagnosis,sex,diagnosis_sex_interaction,Scaling,File,tbv,tbv_dm,age,age_dm
1,0,0,1,/media/sf_Spharm/14753.1/spharm/14753.1_Lhipp_surfSPHARM_ellalign.vtk,0.1618064,0.007095606,5.61,-1.384223301
0,0,0,1,/media/sf_Spharm/15397.1/spharm/15397.1_Lhipp_surfSPHARM_ellalign.vtk,0.1607335,0.006022706,6.75,-0.244223301
1,0,0,1,/media/sf_Spharm/15403.1/spharm/15403.1_Lhipp_surfSPHARM_ellalign.vtk,0.1522853,-0.002425494,7.82,0.825776699
0,0,0,1,/media/sf_Spharm/15407.1/spharm/15407.1_Lhipp_surfSPHARM_ellalign.vtk,0.1629996,0.008288806,4.86,-2.134223301
1,0,0,1,/media/sf_Spharm/15433.1/spharm/15433.1_Lhipp_surfSPHARM_ellalign.vtk,0.1516102,-0.003100594,5.15,-1.844223301
0,0,0,1,/media/sf_Spharm/15461.1/spharm/15461.1_Lhipp_surfSPHARM_ellalign.vtk,0.1483783,-0.006332494,7.37,0.375776699
1,0,0,1,/media/sf_Spharm/15462.1/spharm/15462.1_Lhipp_surfSPHARM_ellalign.vtk,0.1542314,-0.000479394,6.91,-0.084223301
1,0,0,1,/media/sf_Spharm/15467.1/spharm/15467.1_Lhipp_surfSPHARM_ellalign.vtk,0.1723395,0.017628706,6.26,-0.734223301
1,0,0,1,/media/sf_Spharm/15473.1/spharm/15473.1_Lhipp_surfSPHARM_ellalign.vtk,0.1689724,0.014261606,6.11,-0.884223301
Thanks again,
Lara
Threaded View
Title | Author | Date |
---|---|---|
Lara Foland-Ross | Nov 4, 2015 | |
Lara Foland-Ross | Nov 6, 2015 | |
Beatriz Paniagua | Nov 9, 2015 | |
Lara Foland-Ross | Nov 9, 2015 | |
D J | Nov 10, 2015 | |
Martin Styner | Nov 10, 2015 | |
Lara Foland-Ross | Nov 10, 2015 | |
Martin Styner | Nov 11, 2015 | |
Lara Foland-Ross | Nov 11, 2015 | |
Beatriz Paniagua | Nov 12, 2015 | |
Martin Styner | Nov 12, 2015 | |
Lara Foland-Ross | Nov 17, 2015 | |
Beatriz Paniagua | Nov 18, 2015 | |
Lara Foland-Ross | Nov 18, 2015 | |
Lara Foland-Ross | Nov 23, 2015 | |
Lara Foland-Ross | Nov 30, 2015 | |
Beatriz Paniagua | Nov 30, 2015 | |
Beatriz Paniagua | Dec 1, 2015 | |
Lara Foland-Ross | Dec 2, 2015 | |
Beatriz Paniagua | Dec 8, 2015 | |
Lara Foland-Ross | Nov 9, 2015 | |
D J | Nov 9, 2015 | |